Dennis Robins, MD
Urology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Robins’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A178476 · Current
Licensed to practise in California · since 2022 · expires 2028-05-31 · State University of New York, Downstate Medical Center College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$71,640
Pharmacies billed $71,640 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
584 generic and fewer than 11 brand-name prescriptions · $71,640 in drug cost · 183 antibiotic prescriptions to 134 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 85 | $46,202 | $544 |
| Mirabegron Er | 40 | $12,441 | $311 |
| Finasteride | 104 | $1,670 | $16 |
| Trospium Chloride Er | 13 | $1,494 | $115 |
| Tamsulosin | 84 | $1,406 | $17 |
See all 13 drugs
| Myrbetriq | 85 | $46,202 | $544 |
| Mirabegron Er | 40 | $12,441 | $311 |
| Finasteride | 104 | $1,670 | $16 |
| Trospium Chloride Er | 13 | $1,494 | $115 |
| Tamsulosin | 84 | $1,406 | $17 |
| Trospium Chloride | 31 | $1,153 | $37 |
| Tadalafil | 38 | $897 | $24 |
| Estradiol | 12 | $560 | $47 |
| Ciprofloxacin | 78 | $536 | $7 |
| Nitrofurantoin Mono-Macro | 20 | $408 | $20 |
| Sulfamethoxazole-Trimethoprim | 57 | $360 | $6 |
| Cephalexin | 17 | $166 | $10 |
| Ibuprofen | 18 | $125 | $7 |
Year by year
| 2024 | 676 | 287 | None | None | $71,640 |
| 2023 | 550 | 229 | 2% (13) | None | $68,079 |
| 2022 | 152 | 96 | 0% (0) | 11% | $12,612 |
| 2021 | 62 | 49 | None | None | $717 |
| 2020 | 60 | 48 | None | 0% | $368 |
| 2019 | 119 | 71 | 0% (0) | None | $2,934 |
| 2018 | 95 | 62 | None | None | $3,545 |
| 2017 | 17 | None | 0% (0) | 0% | $162 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Myrbetriq | 109 | $54,881 | $503 |
| Trospium Chloride Er | 42 | $2,524 | $60 |
| Tamsulosin | 82 | $1,336 | $16 |
| Finasteride | 81 | $1,163 | $14 |
| Methenamine Hippurate | 13 | $914 | $70 |
| Tadalafil | 32 | $856 | $27 |
| Nitrofurantoin Mono-Macro | 22 | $644 | $29 |
| Estradiol | 12 | $553 | $46 |
| Terazosin | 11 | $527 | $48 |
| Ciprofloxacin | 53 | $370 | $7 |
| Sulfamethoxazole-Trimethoprim | 46 | $288 | $6 |
2022: 7 drugs
| Myrbetriq | 15 | $9,339 | $623 |
| Trospium Chloride Er | 12 | $767 | $64 |
| Oxybutynin Chloride Er | 12 | $591 | $49 |
| Tamsulosin | 31 | $371 | $12 |
| Sulfamethoxazole-Trimethoprim | 34 | $161 | $5 |
| Finasteride | 11 | $159 | $14 |
| Ciprofloxacin | 18 | $114 | $6 |
2021: 2 drugs
| Tamsulosin | 15 | $369 | $25 |
| Sulfamethoxazole-Trimethoprim | 19 | $57 | $3 |
2020: 1 drug
| Sulfamethoxazole-Trimethoprim | 21 | $51 | $2 |
2019: 5 drugs
| Tamsulosin | 29 | $501 | $17 |
| Oxybutynin Chloride Er | 15 | $356 | $24 |
| Finasteride | 13 | $96 | $7 |
| Ciprofloxacin | 27 | $84 | $3 |
| Sulfamethoxazole-Trimethoprim | 15 | $52 | $3 |
2018: 4 drugs
| Oxybutynin Chloride Er | 14 | $216 | $15 |
| Tamsulosin | 15 | $146 | $10 |
| Ciprofloxacin | 22 | $82 | $4 |
| Sulfamethoxazole-Trimethoprim | 15 | $67 | $4 |
Money from drug and device companies
$86 in 2025
| 2025 | 1 | 1 | None | $86 |
| 2020 | 1 | 2 | None | $56 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Xtandi | $86 | 1 payment
|
See the published payment
| Astellas Pharma US | Meals · 2025-11-14 | Xtandi | $86 |
See earlier years (2020)
2020: $56
| Boston Scientific | Ams | $56 | 2 payments
|
Professional record
- NPI
- 1508390063
- Licence
- CA A178476California A178476: Current · expires 2028-05-31
- Trained
- State University of New York Downstate Medical Center, 2016
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X); Student in a training program (390200000X)
- Mailing address
- 450 Clarkson Ave, Brooklyn, NY, 11203
- NPI first listed
- 2017-04-11
- NPI last updated
- 2022-09-15
- NPI record certified
- 2022-09-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.